KUALA LUMPUR: LYC Healthcare Bhd’s 64.5% owned subsidiary, LYC Medicare Singapore Limited has lodged the preliminary offer document with the Singapore Exchange Limited (SGX) Catalist Board.

In a statement, LYC Healthcare said the pivotal step, guided by Evolve Capital Advisory Private Limited as the sponsor, marks a significant milestone in LYC Healthcare’s strategic expansion and growth trajectory.

LYC Healthcare said this strategic initiative is anticipated to support further growth and expansion plans for LYC Healthcare, enhancing liquidity and access to capital markets.

Additionally, it is anticipated to elevate LYC Healthcare’s brand presence in Singapore, fostering greater awareness among consumers and investors in the region.

"Lodging LYC Medicare Singapore's offer document with the SGX marks a significant phase in LYC Healthcare's journey. It aligns with our vision to strengthen our brand in the Southeast Asian healthcare landscape.

“We are eager to embark on this journey, confident that it will enrich our market presence in Singapore and reinforce our commitment to delivering superior healthcare services across the region,” managing director cum group chief executive officer Sui Dong Hoe said.